Buy Biocon; target of Rs 266: Sharekhan
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 266 in its research report dated February 21, 2023.27-02-2023
27-02-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Meetings conducted with Institutional Investors/Research Analysts.24-02-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Meetings conducted with Institutional Investors/Research Analysts23-02-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Meetings conducted with Institutional Investors/Research Analysts23-02-2023
Kotak fund invests Rs 1070 crore in Biocon
Eshwar Karra, CEO Kotak Special Situations Fund at Kotak Investment Advisors said, We are delighted to partner with Biocon and this acquisition financing supports Biocon's journey of becoming a world leading, fully integrated biosimilars enterprise.22-02-2023
BIOCON LTD. - 532523 - Redemption Of Commercial Papers
In terms of the SEBI Operational Circular No. SEBI/HO/DDHS/P/CIR/2021/613 dated 10th August, 2021 (as amended), for issue and listing of Non-convertible Securities, Securitised Debt Instruments, Security Receipts, Municipal Debt Securities and Commercial Paper, we wish to inform you that the Company has fulfilled its payment obligation and has fully redeemed the Commercial Papers (CPs) of Rs. 2,250 Crore22-02-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Call Q3 FY2322-02-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Allotment
Allotment of Non-Convertible Debentures on private placement basis21-02-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Meetings conducted with Institutional Investors/Research Analysts.21-02-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.20-02-2023